Flavonoids in cancer and apoptosis

Cancers

Volumn 11, Issue 1, 2019, Pages

  Abotaleb, Mariam ^a   Samuel, Samson Mathews ^a   Varghese, Elizabeth ^a   Varghese, Sharon ^a   Kubatka, Peter ^b   Liskova, Alena ^b   Büsselberg, Dietrich ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (Qatar)

^b University Hospital in Martin   (Slovakia)

Author keywords

Anti cancer therapy; Apoptosis; Cancer; Flavonoids; Natural compounds; Phytochemicals

Indexed keywords

ACACETIN; APIGENIN; BAICALEIN; CASPASE; CHRYSIN; DAIDZEIN; DELPHINIDIN; DOXORUBICIN; EPICATECHIN; EPIGALLOCATECHIN GALLATE; EUPATORIN; FISETIN; FLAVONOID; FLAVONOL; FLAVOPIRIDOL; GALANGIN; GENISTEIN; HESPERETIN; KAEMPFEROL; LUTEOLIN; MYRICETIN; PELARGONIDIN; PROTEIN BCL 2; QUERCETIN;

APOPTOSIS; CANCER INHIBITION; COLON CANCER; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG EFFICACY; DRUG STRUCTURE; HUMAN; LIVER CELL CARCINOMA; MALIGNANT NEOPLASM; MESOTHELIOMA; NONHUMAN; PHYTOCHEMISTRY; PROSTATE CANCER; REVIEW; SIGNAL TRANSDUCTION;

EID: 85061892477     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers11010028     Document Type: Review

References (291)

1. Igney, F.H.; Krammer, P.H. Death and anti-death: Tumour resistance to apoptosis. Nat. Rev. 2002, 2, 277-288.
2. Safarzadeh, E.; Shotorbani, S.S.; Baradaran, B. Herbal medicine as inducers of apoptosis in cancer treatment. Adv. Pharm. Bull. 2014, 4, 421-427.
3. Prakash, O.; Kumar, A.; Kumar, P. Anticancer potential of plants and natural products: A review. Am. J. Pharmacol. Sci. 2013, 1, 104-115.
4. Hanahan, D.; Weinberg, R.A. Review hallmarks of cancer: The next generation. Cell 2011, 144, 646-674.
5. Hanahan, D.; Weinberg, R.A.; Francisco, S. The hallmarks of cancer review university of california at san francisco. Cell 2000, 100, 57-70.
6. Fan, T.J.; Han, L.H.; Cong, R.S.; Liang, J. Caspase family proteases and apoptosis. Acta Biochim. Biophys. Sin. 2005, 37, 719-727.
7. Indran, I.R.; Tufo, G.; Pervaiz, S.; Brenner, C. Recent advances in apoptosis, mitochondria and drug resistance in cancer cells. Biochim. Biophys. Acta Bioenerget. 2011, 1807, 735-745.
8. Wong, R.S.Y. Apoptosis in cancer: From pathogenesis to treatment. J. Exp. Clin. Cancer Res. 2011, 30, 87.
9. Kasibhatla, S.; Tseng, B. Why target apoptosis in cancer treatment? Mol. Cancer Ther. 2003, 2, 573-580.
10. Opferman, J.T.; Kothari, A. Anti-apoptotic bcl-2 family members in development. Cell Death Differ. 2018, 25, 37-45.
11. Aubrey, B.J.; Kelly, G.L.; Janic, A.; Herold, M.J.; Strasser, A. How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression? Cell Death Differ. 2018, 25, 104-113.
12. Zhao, Y.; Coloff, J.L.; Ferguson, E.C.; Jacobs, S.R.; Cui, K.; Rathmell, J.C. Glucose metabolism attenuates p53 and puma-dependent cell death upon growth factor deprivation. J. Biol. Chem. 2008, 283, 36344-36353.
13. Rathore, R.; McCallum, J.E.; Varghese, E.; Maria, A.; Büsselberg, D. Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (iaps). Apoptosis 2017, 22, 898-919.
14. Lopez, J.; Tait, S.W.G. Mitochondrial apoptosis: Killing cancer using the enemy within. Br. J. Cancer 2015, 112, 957-962.
15. Chwieralski, C.E.; Welte, T.; Bühling, F. Cathepsin-regulated apoptosis. Apoptosis 2006, 11, 143-149.
16. Manzl, C.; Krumschnabel, G.; Bock, F.; Sohm, B.; Labi, V.; Baumgartner, F.; Logette, E.; Tschopp, J.; Villunger, A. Caspase-2 activation in the absence of piddosome formation. J. Cell Biol. 2009, 185, 291-303.
17. Boehning, D.; Patterson, R.L.; Sedaghat, L.; Glebova, N.O.; Kurosaki, T.; Snyder, S.H.; Insp, R. Cytochrome c binds to inositol (1,4,5) trisphosphate receptors, amplifying calcium-dependent apoptosis. Nat. Cell Biol. 2003, 5, 1051.
18. Momeni, H.R.; Ph, D. Role of calpain in apoptosis. Cell J. 2011, 13, 65-72.
19. Stewart, T.A.; Yapa, K.T.D.S.; Monteith, G.R. Altered calcium signaling in cancer cells. Biochim. Biophys. Acta 2015, 1848, 2502-2511.
20. Panche, A.D.; Diwan, A.D.; Chandra, S.R. Flavonoids: An overview. J. Nutr. Sci. 2016, 5, 1-15.
21. Varghese, E.; Samuel, S.M.; Abotaleb, M.; Cheema, S.; Mamtani, R.; Busselberg, D. The “yin and yang” of natural compounds in anticancer therapy of triple-negative breast cancers. Cancers 2018, 10, 346.
22. Liu, R.H. Nutrition, and cancer potential synergy of phytochemicals in cancer prevention: Mechanism of action 1. Int. Res. Conf. Food Nutr. Cancer Potential 2004, 134, 3479-3485.
23. Batra, P.; Sharma, A.K. Anti-cancer potential of flavonoids: Recent trends and future perspectives. Biotech 2013, 3, 439-459.
24. Tapas, A.R.; Sakarkar, D.M.; Kakde, R.B. Flavonoids as nutraceuticals: A review. Trop. J. Pharm. Res. 2008, 7, 1089-1099.
25. Ravishankar, D.; Rajora, A.K.; Greco, F.; Osborn, H.M.I. Flavonoids as prospective compounds for anti-cancer therapy. Int. J. Biochem. Cell Biol. 2013, 45, 2821-2831.
26. Kelly, G.S. Quercetin. Altern. Med. Rev. 2011, 16, 172-194.
27. Iqbal, J.; Abbasi, B.A.; Mahmood, T.; Kanwal, S.; Ali, B.; Shah, S.A. Plant-derived anticancer agents: A green anticancer approach. Asian Pac. J. Trop. Biomed. 2017, 7, 1129-1150.
28. Parhiz, H.; Roohbakhsh, A.; Soltani, F.; Rezaee, R.; Iranshahi, M. Antioxidant and anti-inflammatory properties of the citrus flavonoids hesperidin and hesperetin: An updated review of their molecular mechanisms and experimental models. Phytother. Res. 2015, 29, 323-331.
29. Zhang, J.; Wu, D.; Vikash; Song, J.; Wang, J.; Yi, J.; Dong, W. Hesperetin induces the apoptosis of gastric cancer cells via activating mitochondrial pathway by increasing reactive oxygen species. Dig. Dis. Sci. 2015, 60, 2985-2995.
30. Wu, D.; Zhang, J.; Wang, J.; Li, J.; Liao, F.; Dong, W. Hesperetin induces apoptosis of esophageal cancer cells via mitochondrial pathway mediated by the increased intracellular reactive oxygen species. Tumor Biol. 2016, 37, 3451-3459.
31. Palit, S.; Kar, S.; Sharma, G.; Das, P.K. Hesperetin induces apoptosis in breast carcinoma by triggering accumulation of ros and activation of ask1/jnk pathway. J. Cell. Physiol. 2015, 230, 1729-1739.
32. Sivagami, G.; Vinothkumar, R.; Preethy, C.P.; Riyasdeen, A.; Akbarsha, M.A.; Menon, V.P.; Nalini, N. Role of hesperetin (a natural flavonoid) and its analogue on apoptosis in ht-29 human colon adenocarcinoma cell line-A comparative study. Food Chem. Toxicol. 2012, 50, 660-671.
33. Elango, R.; Athinarayanan, J.; Subbarayan, V.P.; Lei, D.K.Y.; Alshatwi, A.A. Hesperetin induces an apoptosis-triggered extrinsic pathway and a p53-independent pathway in human lung cancer h522 cells. J. Asian Nat. Prod. Res. 2017, 6020, 1-11.
34. Alshatwi, A.A.; Ramesh, E.; Periasamy, V.S.; Subash-Babu, P. The apoptotic effect of hesperetin on human cervical cancer cells is mediated through cell cycle arrest, death receptor, and mitochondrial pathways. Fund. Clin. Pharmacol. 2013, 27, 581-592.
35. Sambantham, S.; Radha, M.; Paramasivam, A.; Anandan, B.; Malathi, R.; Chandra, S.R.; Jayaraman, G. Molecular mechanism underlying hesperetin-induced apoptosis by in silico analysis and in prostate cancer pc-3 cells. Asian Pac. J. Cancer Prev. 2013, 14, 4347-4352.
36. Patel, K.; Singh, G.K.; Patel, D.K. A review on pharmacological and analytical aspects of naringenin. Chin. J. Integr. Med. 2014, 24, 551-560.
37. Bao, L.; Liu, F.; Guo, H.B.; Li, Y.; Tan, B.B.; Zhang, W.X.; Peng, Y.H. Naringenin inhibits proliferation, migration, and invasion as well as induces apoptosis of gastric cancer sgc7901 cell line by downregulation of akt pathway. Tumor Biol. 2016, 37, 11365-11374.
38. Zhang, H.; Zhong, X.; Zhang, X.; Shang, D.; Zhou, Y.; Zhang, C. Enhanced anticancer effect of abt-737 in combination with naringenin on gastric cancer cells. Exp. Ther. Med. 2016, 11, 669-673.
39. Ahamad, M.S.; Siddiqui, S.; Jafri, A.; Ahmad, S.; Afzal, M.; Arshad, M. Induction of apoptosis and antiproliferative activity of naringenin in human epidermoid carcinoma cell through ros generation and cell cycle arrest. PLoS ONE 2014, 9, e110003.
40. Arul, D.; Subramanian, P. Naringenin (citrus flavonone) induces growth inhibition, cell cycle arrest and apoptosis in human hepatocellular carcinoma cells. Pathol. Oncol. Res. 2013, 19, 763-770.
41. Kapoor, R.; Rizvi, F.; Kakkar, P. Naringenin prevents high glucose-induced mitochondria-mediated apoptosis involving aif, endo-g and caspases. Apoptosis 2013, 18, 9-27.
42. Bulzomi, P.; Bolli, A.; Galluzzo, P.; Acconcia, F.; Ascenzi, P.; Marino, M. The naringenin-induced proapoptotic effect in breast cancer cell lines holds out against a high bisphenol a background. IUBMB Life 2012, 64, 690-696.
43. Krishnakumar, N.; Sulfikkarali, N.; RajendraPrasad, N.; Karthikeyan, S. Enhanced anticancer activity of naringenin-loaded nanoparticles in human cervical (hela) cancer cells. Biomed. Prev. Nutr. 2011, 1, 223-231.
44. Kim, J.H.; Kang, J.W.; Kim, M.S.; Bak, Y.; Park, Y.S.; Jung, K.Y.; Lim, Y.H.; Yoon, D.Y. The apoptotic effects of the flavonoid n101-2 in human cervical cancer cells. Toxicol. In Vitro 2012, 26, 67-73.
45. Park, H.J.; Choi, Y.J.; Lee, J.H.; Nam, M.J. Naringenin causes ask1-induced apoptosis via reactive oxygen species in human pancreatic cancer cells. Food Chem. Toxicol. 2017, 99, 1-8.
46. Abdulkhaleq, L.A.; Assi, M.A.; Noor, M.H.M.; Abdullah, R.; Saad, M.Z.; Taufiq-Yap, Y.H. Therapeutic uses of epicatechin in diabetes and cancer. Vet. World 2017, 10, 869-872.
47. Shay, J.; Elbaz, H.A.; Lee, I.; Zielske, S.P.; Malek, M.H. Molecular mechanisms and therapeutic effects of (-)-epicatechin and other polyphenols in cancer, inflammation, diabetes, andneurodegeneration. Oxid. Med. Cell. Longev. 2015, 2015, 181260.
48. Amin, A.; Gali-muhtasib, H.; Ocker, M.; Schneider-stock, R. Overview of major classes of plant-derived anticancer drugs. Int. J. Biomed. Sci. 2009, 5, 1-11.
49. Moradzadeh, M.; Hosseini, A.; Erfanian, S.; Rezaei, H. Epigallocatechin-3-gallate promotes apoptosis in human breast cancer t47d cells through down-regulation of pi3k/akt and telomerase. Pharmacol. Rep. 2017, 69, 924-928.
50. Li, M.-J. Green tea compounds in breast cancer prevention and treatment. World J. Clin. Oncol. 2014, 5, 520.
51. Liu, L.; Hou, L.; Gu, S.; Zuo, X.; Meng, D.; Luo, M.; Zhang, X.; Huang, S.; Zhao, X. Molecular mechanism of epigallocatechin-3-gallate in human esophageal squamous cell carcinoma in vitro and in vivo. Oncol. Rep. 2015, 33, 297-303.
52. Cerezo-Guisado, M.I.; Zur, R.; Lorenzo, M.J.; Risco, A.; Martín-Serrano, M.A.; Alvarez-Barrientos, A.; Cuenda, A.; Centeno, F. Implication of akt, erk1/2 and alternative p38mapk signalling pathways in human colon cancer cell apoptosis induced by green tea egcg. Food Chem. Toxicol. 2015, 84, 125-132.
53. Kwak, T.W.; Park, S.B.; Kim, H.J.; Jeong, Y.I.L.; Kang, D.H. Anticancer activities of epigallocatechin-3-gallate against cholangiocarcinoma cells. OncoTargets Ther. 2017, 10, 137-144.
54. Sonoda, J.I.; Ikeda, R.; Baba, Y.; Narumi, K.; Kawachi, A.; Tomishige, E.; Nishihara, K.; Takeda, Y.; Yamada, K.; Sato, K.; et al. Green tea catechin, epigallocatechin-3-gallate, attenuates the cell viability of human non-small-cell lung cancer a549 cells via reducing bcl-xl expression. Exp. Ther. Med. 2014, 8, 59-63.
55. Fantini, M.; Benvenuto, M.; Masuelli, L.; Frajese, G.V.; Tresoldi, I.; Modesti, A.; Bei, R. In vitro and in vivo antitumoral effects of combinations of polyphenols, or polyphenols and anticancer drugs: Perspectives on cancer treatment. Int. J. Mol. Sci. 2015, 16, 9236-9282.
56. Gupta, S.; Hastak, K.; Afaq, F.; Ahmad, N.; Mukhtar, H. Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor kappa b and induction of apoptosis. Oncogene 2004, 23, 2507-2522.
57. Pan, M.H.; Lin, C.C.; Lin, J.K.; Chen, W.J. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/akt and mitogen-activated protein kinase cascade signaling. J. Agric. Food Chem. 2007, 55, 5030-5037.
58. Pianetti, S.; Guo, S.; Kavanagh, K.T.; Sonenshein, G.E. Green tea polyphenol epigallocatechin-3 gallate inhibits her-2/neu signaling, proliferation, and transformed phenotype of breast cancer cells. Cancer Res. 2002, 62, 652-655.
59. Masuda, M.; Suzui, M.; Lim, J.T.; Deguchi, A.; Soh, J.W.; Weinstein, I.B. Epigallocatechin-3-gallate decreases vegf production in head and neck and breast carcinoma cells by inhibiting egfr-related pathways of signal transduction. J. Exp. Ther. Oncol. 2002, 2, 350-359.
60. Ranganathan, S.; Halagowder, D. Quercetin suppresses twist to induce apoptosis in mcf-7 breast cancer cells. PLoS ONE 2015, 10, e0141370.
61. Damnjanovic, I.; Najman, S.; Stojanovic, S.; Stojanovic, D.; Veljkovic, A.; Kocic, H.; Langerholc, T.; Damnjanovic, Z.; Pesic, S. Quercetin induces apoptosis and necroptosis in mcf-7 breast cancer cells. Bratislavské Lekárske Listy 2017, 116, 227-232.
62. Zhang, L. Quercetin inhibits human breast cancer cell proliferation and induces apoptosis via bcl-2 and bax regulation. Mol. Med. Rep. 2012, 1453-1456.
63. Chou, C.-C.; Yang, J.-S.; Lu, H.-F.; Ip, S.-W.; Lo, C.; Wu, C.-C.; Lin, J.-P.; Tang, N.-Y.; Chung, J.-G.; Chou, M.-J.; et al. Quercetin-mediated cell cycle arrest and apoptosis involving activation of a caspase cascade through the mitochondrial pathway in human breast cancer mcf-7 cells. Arch. Pharm. Res. 2010, 33, 1181-1191.
64. Seo, H.S.; Ku, J.M.; Choi, H.S.; Choi, Y.K.; Woo, J.K.; Kim, M.; Kim, I.; Na, C.H.; Hur, H.; Jang, B.H.; et al. Quercetin induces caspase-dependent extrinsic apoptosis through inhibition of signal transducer and activator of transcription 3 signaling in her2-overexpressing bt-474 breast cancer cells. Oncol. Rep. 2016, 36, 31-42.
65. Niu, G.; Yin, S.; Xie, S.; Li, Y.; Nie, D.; Ma, L.; Wang, X.; Wu, Y. Quercetin induces apoptosis by activating caspase-3 and regulating bcl-2 and cyclooxygenase-2 pathways in human hl-60 cells. Acta Biochim. Biophys. Sin. 2011, 43, 30-37.
66. Granato, M.; Rizzello, C.; Montani, M.S.G.; Cuomo, L.; Vitillo, M.; Santarelli, R.; Gonnella, R.; D’Orazi, G.; Faggioni, A.; Cirone, M. Quercetin induces apoptosis and autophagy in primary effusion lymphoma cells by inhibiting pi3k/akt/mtor and stat3 signaling pathways. J. Nutr. Biochem. 2017, 41, 124-136.
67. Wang, P.; Heber, D.; Henning, S.M. Quercetin increased the antiproliferative activity of green tea polyphenol (-)-epigallocatechin gallate in prostate cancer cells. Nutr. Cancer 2012, 64, 580-587.
68. Sun, S.; Gong, F.; Liu, P.; Miao, Q. Metformin combined with quercetin synergistically repressed prostate cancer cells via inhibition of vegf/pi3k/akt signaling pathway. Gene 2018, 664, 50-57.
69. Jeong, J.H.; An, J.Y.; Kwon, Y.T.; Li, L.Y.; Lee, Y.J. Quercetin-induced ubiquitination and down-regulation of her-2/neu. J. Cell. Biochem. 2008, 105, 585-595.
70. Granado-Serrano, A.B.; Martin, M.A.; Bravo, L.; Goya, L.; Ramos, S. Quercetin modulates nf-kappa b and ap-1/jnk pathways to induce cell death in human hepatoma cells. Nutr. Cancer 2010, 62, 390-401.
71. Calder, M.; Burgos, E. A review on the dietary flavonoid kaempferol. Mini Rev. Med. Chem. 2011, 11, 298-344.
72. Chen, A.Y.; Chen, Y.C. A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention. Food Chem. 2013, 138, 2099-2107.
73. Kim, S.H.; Choi, K.C. Anti-cancer effect and underlying mechanism(s) of kaempferol, a phytoestrogen, on the regulation of apoptosis in diverse cancer cell models. Toxicol. Res. 2013, 29, 229-234.
74. Luo, H.; Jiang, B.; Li, B.; Li, Z.; Jiang, B.H.; Chen, Y.C. Kaempferol nanoparticles achieve strong and selective inhibition of ovarian cancer cell viability. Int. J. Nanomed. 2012, 7, 3951-3959.
75. Li, W.; Du, B.; Wang, T.; Wang, S.; Zhang, J. Kaempferol induces apoptosis in human hct116 colon cancer cells via the ataxia-telangiectasia mutated-p53 pathway with the involvement of p53 upregulated modulator of apoptosis. Chem.-Biol. Interact. 2009, 177, 121-127.
76. Luo, H.; Rankin, G.O.; Li, Z.; DePriest, L.; Chen, Y.C. Kaempferol induces apoptosis in ovarian cancer cells through activating p53 in the intrinsic pathway. Food Chem. 2011, 128, 513-519.
77. Moradzadeh, M.; Tabarraei, A.; Sadeghnia, H.R.; Ghorbani, A.; Mohamadkhani, A.; Erfanian, S.; Sahebkar, A. Kaempferol increases apoptosis in human acute promyelocytic leukemia cells and inhibits multidrug resistance genes. J. Cell. Biochem. 2018, 119, 2288-2297.
78. Luo, H.; Daddysman, M.K.; Rankin, G.O.; Jiang, B.H.; Chen, Y.C. Kaempferol enhances cisplatin’s effect on ovarian cancer cells through promoting apoptosis caused by down regulation of cmyc. Cancer Cell Int. 2010, 10, 1-9.
79. Guo, H.; Ren, F.; Zhang, L.I.; Zhang, X.; Yang, R. Kaempferol induces apoptosis in hepg2 cells via activation of the endoplasmic reticulum stress pathway. Mol. Med. Rep. 2016, 13, 2791-2800.
80. Jeong, J.C.; Kim, M.S.; Kim, T.H.; Kim, Y.K. Kaempferol induces cell death through erk and akt-dependent down-regulation of xiap and survivin in human glioma cells. Neurochem. Res. 2009, 34, 991-1001.
81. Kashafi, E.; Moradzadeh, M.; Mohamadkhani, A.; Erfanian, S. Kaempferol increases apoptosis in human cervical cancer hela cells via pi3k/akt and telomerase pathways. Biomed. Pharmacother. 2017, 89, 573-577.
82. Khan, N.; Syed, D.N.; Ahmad, N.; Mukhtar, H. Fisetin: A dietary antioxidant for health promotion. Antioxid. Redox Signal. 2013, 19, 151-162.
83. Khan, N.; Afaq, F.; Syed, D.N. Fisetin, a novel dietary flavonoid, causes apoptosis and cell cycle arrest in human prostate cancer lncap cells. Carcinogenesis 2018, 29, 1049-1056.
84. Szliszka, E.; Helewski, K.J.; Mizgala, E.; Krol,W. The dietary flavonol fisetin enhances the apoptosis-inducing potential of trail in prostate cancer cells. Int. J. Oncol. 2011, 39, 771-779.
85. Sabarwal, A.; Agarwal, R.; Singh, R.P. Fisetin inhibits cellular proliferation and inducesmitochondria-dependent apoptosis in human gastric cancer cells. Mol. Carcinogen. 2017, 514, 499-514.
86. Lin, M.-T.; Lin, C.-L.; Lin, T.-Y.; Cheng, C.-W.; Yang, S.-F.; Lin, C.-L.; Wu, C.-C.; Hsieh, Y.-H.; Tsai, J.-P. Synergistic effect of fisetin combined with sorafenib in human cervical cancer hela cells through activation of death receptor-5 mediated caspase-8/caspase-3 and the mitochondria-dependent apoptotic pathway. Tumor Biol. 2015, 60, 1396-1405.
87. Ying, T.H.; Yang, S.F.; Tsai, S.J.; Hsieh, S.C.; Huang, Y.C.; Bau, D.T.; Hsieh, Y.H. Fisetin induces apoptosis in human cervical cancer hela cells through erk1/2-mediated activation of caspase-8-/caspase-3-dependent pathway. Arch Toxicol 2012, 86, 263-273.
88. Kang, K.A.; Piao, M.J.; Ruwan, S.; Madduma, K. Fisetin induces apoptosis and endoplasmic reticulum stress in human non-small cell lung cancer through inhibition of the mapk signaling pathway. Tumor Biol. 2016, 37, 9615-9624.
89. Yi, C.; Zhang, Y.; Yu, Z.; Xiao, Y.; Wang, J.; Qiu, H.; Yu, W.; Tang, R.; Yuan, Y.; Guo, W.; et al. Melatonin enhances the anti-tumor effect of fisetin by inhibiting cox-2/inos and nf-kb/p300 signaling pathways. PLoS ONE 2014, 9, e99943.
90. Young, K.; Jeong, S.-J.; Kim, S.-H.; Hoon, J.; Kim, J.-H.; Koh,W.; Chen, C.-Y.; Kim, S.-H. Activation of reactive oxygen species/amp activated protein kinase signaling mediates fisetin-induced apoptosis in multiple myeloma u266 cells. Cancer Lett. 2012, 319, 197-202.
91. Devi, K.P.; Rajavel, T.; Habtemariam, S.; Nabavi, S.F.; Nabavi, S.M. Molecular mechanisms underlying anticancer effects of myricetin. Life Sci. 2015, 142, 19-25.
92. Kim, M.E.; Ha, T.K.; Yoon, J.H.; Lee, J.S. Myricetin induces cell death of human colon cancer cells. Anticancer Res. 2014, 34, 701-706.
93. Kim, W.; Yang, H.J.; Youn, H.; Yun, Y.J.; Seong, K.M.; Youn, B. Myricetin inhibits akt survival signaling and induces bad-mediated apoptosis in a low dose ultraviolet (uv)-b-irradiated hacat human immortalized keratinocytes. J. Radiat. Res. 2010, 51, 285-296.
94. Xu, Y.; Xie, Q.; Wu, S.; Yi, D.; Yu, Y.; Liu, S.; Li, S.; Li, Z. Myricetin induces apoptosis via endoplasmic reticulum stress and DNA double-strand breaks in human ovarian cancer cells. Mol. Med. Rep. 2016, 13, 2094-2100.
95. Huang, H.; Chen, A.Y.; Ye, X.; Li, B.; Rojanasakul, Y.; Rankin, G.O.; Chen, Y.C. Myricetin inhibits proliferation of cisplatin-resistant cancer cells through a p53-dependent apoptotic pathway. Int. J. Oncol. 2015, 47, 1494-1502.
96. Knickle, A.; Fernando,W.; Greenshields, A.L.; Rupasinghe, H.P.V.; Hoskin, D.W. Myricetin-induced apoptosis of triple-negative breast cancer cells is mediated by the iron-dependent generation of reactive oxygen species from hydrogen peroxide. Food Chem. Toxicol. 2018, 118, 154-167.
97. Lirdprapamongkol, K.; Sakurai, H.; Abdelhamed, S.; Yokoyama, S.; Athikomkulchai, S.; Viriyaroj, A.; Awale, S.; Ruchirawat, S.; Svasti, J.; Saiki, I. Chrysin overcomes trail resistance of cancer cells through mcl-1 downregulation by inhibiting stat3 phosphorylation. Int. J. Oncol. 2013, 43, 329-337.
98. Kim, D.A.; Jeon, Y.K.; Nam, M.J. Galangin induces apoptosis in gastric cancer cells via regulation of ubiquitin carboxy-terminal hydrolase isozyme l1 and glutathione s-transferase p. Food Chem. Toxicol. 2012, 50, 684-688.
99. Zhang, H.-T. Galangin induces apoptosis of hepatocellular carcinoma cells via the mitochondrial pathway. World J. Gastroenterol. 2010, 16, 3377.
100. Zhang, H.T.; Wu, J.; Wen, M.; Su, L.J.; Luo, H. Galangin induces apoptosis in hepatocellular carcinoma cells through the caspase 8/t-bid mitochondrial pathway. J. Asian Nat. Prod. Res. 2012, 14, 626-633.
101. Zhang, W.; Lan, Y.; Huang, Q.; Hua, Z. Galangin induces b16f10 melanoma cell apoptosis via mitochondrial pathway and sustained activation of p38 mapk. Cytotechnology 2013, 65, 447-455.
102. Ren, K.; Zhang, W.; Wu, G.; Ren, J.; Lu, H.; Li, Z.; Han, X. Synergistic anti-cancer effects of galangin and berberine through apoptosis induction and proliferation inhibition in oesophageal carcinoma cells. Biomed. Pharmacother. 2016, 84, 1748-1759.
103. Rasul, A.; Zhao, B.J.; Liu, J.; Liu, B.; Sun, J.X.; Li, J.; Li, X.M. Molecular mechanisms of casticin action:An update on its antitumor functions. Asian Pac. J. Cancer Prev. 2014, 15, 9049-9058.
104. Chan, E.W.C.; Wong, S.K.; Chan, H.T. Casticin from vitex species: A short review on its anticancer and anti-inflammatory properties. J. Integr. Med. 2018, 16, 147-152.
105. Zhou, Y.; Peng, Y.; Mao, Q.Q.; Li, X.; Chen, M.W.; Su, J.; Tian, L.; Mao, N.Q.; Long, L.Z.; Quan, M.F.; et al. Casticin induces caspase-mediated apoptosis via activation of mitochondrial pathway and upregulation of dr5 in human lung cancer cells. Asian Pac. J. Trop. Med. 2013, 6, 372-378.
106. Zhou, Y.; Tian, L.; Long, L.; Quan, M.; Liu, F.; Cao, J. Casticin potentiates trail-induced apoptosis of gastric cancer cells through endoplasmic reticulum stress. PLoS ONE 2013, 8, e58855.
107. Ding, C.; Khan, M.; Zheng, B.; Yang, J.; Zhong, L.; Ma, T. Casticin induces apoptosis and mitotic arrest in pancreatic carcinoma panc-1 cells. Afr. J. Pharm. Pharmacol. 2012, 6, 412-418.
108. Meng, F.-M.; Yang, J.-B.; Yang, C.-H.; Jiang, Y.; Zhou, Y.-F.; Yu, B.; Yang, H. Vitexicarpin induces apoptosis in human prostate carcinoma pc-3 cells through g2/m phase arrest. Asian Pac. J. Cancer Prev. 2012, 13, 6369-6374.
109. Chonghao,W. Vitexicarpin induces apoptosis-independent mitotic arrest in u87 glioblastoma cells. Afr. J. Pharm. Pharmacol. 2012, 6, 1874-1882.
110. Liu, E.; Kuang, Y.; He, W.; Xing, X.; Gu, J. Casticin induces human glioma cell death through apoptosis and mitotic arrest. Cell. Physiol. Biochem. 2013, 31, 805-814.
111. Song, X.-L.; Zhang, Y.-J.; Wang, X.-F.; Zhang, W.-J.; Wang, Z.; Zhang, F.; Zhang, Y.-J.; Lu, J.-H.; Mei, J.-W.; Hu, Y.-P.; et al. Casticin induces apoptosis and g0/g1 cell cycle arrest in gallbladder cancer cells. Cancer Cell Int. 2017, 17, 9.
112. Mason, A. Plant flavone apigenin inhibits hdac and remodels chromatin to induce growth arrest and apoptosis in human prostate cancer cells: In vitro and in vivo study. Mol. Carcinogen. 2012, 51, 952-962.
113. Shukla, S.; Fu, P.; Gupta, S. Apigenin induces apoptosis by targeting inhibitor of apoptosis proteins and ku70-bax interaction in prostate cancer. Apoptosis 2014, 19, 883-894.
114. Chan, L.P.; Chou, T.H.; Ding, H.Y.; Chen, P.R.; Chiang, F.Y.; Kuo, P.L.; Liang, C.H. Apigenin induces apoptosis via tumor necrosis factor receptor-and bcl-2-mediated pathway and enhances susceptibility of head and neck squamous cell carcinoma to 5-fluorouracil and cisplatin. Biochim. Biophys. Acta Gen. Subj. 2012, 1820, 1081-1091.
115. Meng, S.; Zhu, Y.; Li, J.-F.; Wang, X.; Liang, Z.; Li, S.-Q.; Xu, X. Apigenin inhibits renal cell carcinoma cell proliferation. Oncotarget 2017, 8, 19834-19842.
116. Shi, M.D.; Shiao, C.K.; Lee, Y.C.; Shih, Y.W. Apigenin, a dietary flavonoid, inhibits proliferation of human bladder cancer T-24 cells via blocking cell cycle progression and inducing apoptosis. Cancer Cell Int. 2015, 15, 1-12.
117. Zhu, Y.; Mao, Y.Q.; Chen, H.; Lin, Y.W.; Hu, Z.H.; Wu, J.; Xu, X.; Xu, X.L.; Qin, J.; Xie, L.P. Apigenin promotes apoptosis, inhibits invasion and induces cell cycle arrest of t24 human bladder cancer cells. Cancer Cell Int. 2013, 13, 1-7.
118. Wang, Q.R.; Yao, X.Q.; Wen, G.; Fan, Q.; Li, Y.J.; Fu, X.Q.; Li, C.K.; Sun, X.G. Apigenin suppresses the growth of colorectal cancer xenografts via phosphorylation and up-regulated fadd expression. Oncol. Lett. 2011, 2, 43-47.
119. Zhang, L.; Cheng, X.; Gao, Y.; Zheng, J.; Xu, Q.; Sun, Y.; Guan, H.; Yu, H.; Sun, Z. Apigenin induces autophagic cell death in human papillary thyroid carcinoma bcpap cells. Food Funct. 2015, 6, 3464-3472.
120. Liu, R.; Ji, P.; Liu, B.; Qiao, H.; Wang, X.; Zhou, L.; Deng, T.; Ba, Y. Apigenin enhances the cisplatin cytotoxic effect through p53-modulated apoptosis. Oncol. Lett. 2017, 13, 1024-1030.
121. Masuelli, L.; Marzocchella, L.; Quaranta, A.; Palumbo, C.; Pompa, G.; Izzi, V.; Canini, A.; Modesti, A.; Galvano, F.; Bei, R. Apigenin induces apoptosis and impairs head and neck carcinomas egfr/erbb2 signaling. Front. Biosci. 2011, 16, 1060-1068.
122. Masuelli, L.; Benvenuto, M.; Mattera, R.; Di Stefano, E.; Zago, E.; Taffera, G.; Tresoldi, I.; Giganti, M.G.; Frajese, G.V.; Berardi, G.; et al. In vitro and in vivo anti-tumoral effects of the flavonoid apigenin in malignant mesothelioma. Front. Pharmacol. 2017, 8, 373.
123. Shukla, S.; Gupta, S. Apigenin-induced cell cycle arrest is mediated by modulation of mapk, pi3k-akt, and loss of cyclin d1 associated retinoblastoma dephosphorylation in human prostate cancer cells. Cell Cycle 2007, 6, 1102-1114.
124. Mehdi, S.H.; Nafees, S.; Khan, A.; Rizvi, M.A. Chrysin: A promising anticancer agent its current trends and future imedpub journals chrysin: A promising anticancer agent its current trends and future perspectives. Eur. J. Exp. Biol. 2018, 8, 16.
125. Kasala, E.R.; Bodduluru, L.N.; Madana, R.M.; Athira, K.V.; Gogoi, R.; Barua, C.C. Chemopreventive and Therapeutic Potential of Chrysin in Cancer: Mechanistic Perspectives; Elsevier Ireland Ltd.: Amsterdam, The Netherlands, 2015; Volume 233, pp. 214-225.
126. Khoo, B.Y.; Chua, S.L.; Balaram, P. Apoptotic effects of chrysin in human cancer cell lines. Int. J. Mol. Sci. 2010, 11, 2188-2199.
127. Li, X.; Wang, J.N.; Huang, J.M.; Xiong, X.K.; Chen, M.F.; Ong, C.N.; Shen, H.M.; Yang, X.F. Chrysin promotes tumor necrosis factor (tnf)-related apoptosis-inducing ligand (trail) induced apoptosis in human cancer cell lines. Toxicol. In Vitro 2011, 25, 630-635.
128. Ryu, S.; Lim, W.; Bazer, F.W.; Song, G. Chrysin induces death of prostate cancer cells by inducing ros and er stress. J. Cell. Physiol. 2017, 232, 3786-3797.
129. Xue, C.; Chen, Y.; Hu, D.N.; Iacob, C.; Lu, C.; Huang, Z. Chrysin induces cell apoptosis in human uveal melanoma cells via intrinsic apoptosis. Oncol. Lett. 2016, 4813-4820.
130. Li, X.; Huang, J.M.;Wang, J.N.; Xiong, X.K.; Yang, X.F.; Zou, F. Combination of chrysin and cisplatin promotes the apoptosis of hep g2 cells by up-regulating p53. Chem.-Biol. Interact. 2015, 232, 12-20.
131. Zhang, Q.; Ma, S.; Liu, B.; Liu, J.; Zhu, R.; Li, M. Chrysin induces cell apoptosis via activation of the p53/bcl-2/caspase-9 pathway in hepatocellular carcinoma cells. Exp. Ther. Med. 2016, 12, 469-474.
132. Chen, Z.; Kong, S.; Song, F.; Li, L.; Jiang, H. Pharmacokinetic study of luteolin, apigenin, chrysoeriol and diosmetin after oral administration of flos chrysanthemi extract in rats. Fitoterapia 2012, 83, 1616-1622.
133. Tuorkey, M.J. Molecular targets of luteolin in cancer. Eur. J. Cancer Prev. 2016, 25, 65-76.
134. Hwang, J.T.; Park, O.J.; Lee, Y.K.; Sung, M.J.; Hur, H.J.; Kim, M.S.; Ha, J.H.; Kwon, D.Y. Anti-tumor effect of luteolin is accompanied by amp-activated protein kinase and nuclear factor-_b modulation in hepg2 hepatocarcinoma cells. Int. J. Mol. Med. 2011, 28, 25-31.
135. Lee, H.J.; Wang, C.J.; Kuo, H.C.; Chou, F.P.; Jean, L.F.; Tseng, T.H. Induction apoptosis of luteolin in human hepatoma hepg2 cells involving mitochondria translocation of bax/bak and activation of jnk. Toxicol. Appl. Pharmacol. 2005, 203, 124-131.
136. Cai, X.; Ye, T.; Liu, C.; Lu, W.; Lu, M.; Zhang, J.; Wang, M.; Cao, P. Luteolin induced g2 phase cell cycle arrest and apoptosis on non-small cell lung cancer cells. Toxicol. In Vitro 2011, 25, 1385-1391.
137. Jiang, Z.-Q.; Li, M.-H.; Qin, Y.-M.; Jiang, H.-Y.; Zhang, X.;Wu, M.-H. Luteolin inhibits tumorigenesis and induces apoptosis of non-small cell lung cancer cells via regulation of microrna-34a-5p. Int. J. Mol. Sci. 2018, 19, 447.
138. Yang, S.F.; Yang, W.E.; Chang, H.R.; Chu, S.C.; Hsieh, Y.S. Luteolin induces apoptosis in oral squamous cancer cells. J. Dent. Res. 2008, 87, 401-406.
139. Park, S.H.; Park, H.S.; Lee, J.H.; Chi, G.Y.; Kim, G.Y.; Moon, S.K.; Chang, Y.C.; Hyun, J.W.; Kim, W.J.; Choi, Y.H. Induction of endoplasmic reticulum stress-mediated apoptosis and non-canonical autophagy by luteolin in nci-h460 lung carcinoma cells. Food Chem. Toxicol. 2013, 56, 100-109.
140. Wang, Q.; Wang, H.; Jia, Y.; Pan, H.; Ding, H. Luteolin induces apoptosis by ros/er stress and mitochondrial dysfunction in gliomablastoma. Cancer Chemother. Pharmacol. 2017, 79, 1031-1041.
141. Johnson, J.L.; Gonzalez de Mejia, E. Interactions between dietary flavonoids apigenin or luteolin and chemotherapeutic drugs to potentiate anti-proliferative effect on human pancreatic cancer cells, in vitro. Food Chem. Toxicol. 2013, 60, 83-91.
142. Yang, M.Y.; Wang, C.J.; Chen, N.F.; Ho, W.H.; Lu, F.J.; Tseng, T.H. Luteolin enhances paclitaxel-induced apoptosis in human breast cancer mda-mb-231 cells by blocking stat3. Chem.-Biol. Interact. 2014, 213, 60-68.
143. Cook, M.T.; Liang, Y.; Besch-Williford, C.; Hyder, S.M. Luteolin inhibits lung metastasis, cell migration, and viability of triple-negative breast cancer cells. Breast Cancer Targets Ther. 2016, 9, 9-19.
144. Ham, S.; Kim, K.H.; Kwon, T.H.; Bak, Y.; Lee, D.H.; Song, Y.S.; Park, S.H.; Park, Y.S.; Kim, M.S.; Kang, J.W.; et al. Luteolin induces intrinsic apoptosis via inhibition of e6/e7 oncogenes and activation of extrinsic and intrinsic signaling pathways in hpv-18-associated cells. Oncol. Rep. 2014, 31, 2683-2691.
145. Bo, W.; Zhao, X.H. Apigenin induces both intrinsic and extrinsic pathways of apoptosis in human colon carcinoma hct-116 cells. Oncol. Rep. 2017, 37, 1132-1140.
146. Chen, H.; Gao, Y.; Wu, J.; Chen, Y.; Chen, B.; Hu, J.; Zhou, J. Exploring therapeutic potentials of baicalin and its aglycone baicalein for hematological malignancies. Cancer Lett. 2014, 354, 5-11.
147. Gao, Y.; Snyder, S.A.; Smith, J.N.; Chen, Y.C. Anticancer properties of baicalein: A review. Med. Chem. Res. 2016, 25, 1515-1523.
148. Takahashi, H.; Chen, M.C.; Pham, H.; Angst, E.; King, J.C.; Park, J.; Brovman, E.Y.; Ishiguro, H.; Harris, D.M.; Reber, H.A.; et al. Baicalein, a component of scutellaria baicalensis, induces apoptosis by mcl-1 down-regulation in human pancreatic cancer cells. Biochim. Biophys. Acta Mol. Cell Res. 2011, 1813, 1465-1474.
149. Zhou, R.-T.; He, M.; Yu, Z.; Liang, Y.; Nie, Y.; Tai, S.; Teng, C.-B. Baicalein inhibits pancreatic cancer cell proliferation and invasion via suppression of nedd9 expression and its downstream akt and erk signaling pathways. Oncotarget 2017, 8, 56351-56363.
150. Chai, Y.; Xu, J.; Yan, B. The anti-metastatic effect of baicalein on colorectal cancer. Oncol. Rep. 2017, 37, 2317-2323.
151. Kim, S.J.; Kim, H.J.; Kim, H.R.; Lee, S.H.; Cho, S.D.; Choi, C.S.; Nam, J.S.; Jung, J.Y. Antitumor actions of baicalein and wogonin in ht-29 human colorectal cancer cells. Mol. Med. Rep. 2012, 6, 1443-1449.
152. Mu, J.; Liu, T.; Jiang, L.;Wu, X.; Cao, Y.; Li, M.; Dong, Q.; Liu, Y.; Xu, H. The traditional chinese medicine baicalein potently inhibits gastric cancer cells. J. Cancer 2016, 7, 453-461.
153. Liu, H.; Dong, Y.; Gao, Y.; Du, Z.;Wang, Y.; Cheng, P.; Chen, A.; Huang, H. The fascinating effects of baicalein on cancer: A review. Int. J. Mol. Sci. 2016, 17, 1681.
154. Peng, Y.; Guo, C.; Yang, Y.; Li, F.; Zhang, Y.; Jiang, B.; Li, Q. Baicalein induces apoptosis of human cervical cancer hela cells in vitro. Mol. Med. Rep. 2015, 11, 2129-2134.
155. Wang, Z.; Jiang, C.; Chen,W.; Zhang, G.; Luo, D.; Cao, Y.; Wu, J.; Ding, Y.; Liu, B. Baicalein induces apoptosis and autophagy via endoplasmic reticulum stress in hepatocellular carcinoma cells. Biomed. Res. Int. 2014, 2014, 732516.
156. Cirmi, S.; Ferlazzo, N.; Lombardo, G.E.; Maugeri, A.; Calapai, G.; Gangemi, S.; Navarra, M. Chemopreventive agents and inhibitors of cancer hallmarks: May citrus offer new perspectives? Nutrients 2016, 8, 698.
157. Periyasamy, K.; Baskaran, K.; Ilakkia, A.; Vanitha, K.; Selvaraj, S.; Sakthisekaran, D. Antitumor efficacy of tangeretin by targeting the oxidative stress mediated on 7,12-dimethylbenz(a) anthracene-induced proliferative breast cancer in sprague-dawley rats. Cancer Chemother. Pharmacol. 2015, 75, 263-272.
158. Arivazhagan, L.; Sorimuthu Pillai, S. Tangeretin, a citrus pentamethoxyflavone, exerts cytostatic effect via p53/p21 up-regulation and suppresses metastasis in 7,12-dimethylbenz(_)anthracene-induced rat mammary carcinoma. J. Nutr. Biochem. 2014, 25, 1140-1153.
159. Dong, Y.; Cao, A.; Shi, J.; Yin, P.;Wang, L.; Ji, G.; Xie, J.;Wu, D. Tangeretin, a citrus polymethoxyflavonoid, induces apoptosis of human gastric cancer ags cells through extrinsic and intrinsic signaling pathways. Oncol. Rep. 2014, 31, 1788-1794.
160. Ma, L.L.; Wang, D.W.; Yu, X.D.; Zhou, Y.L. Tangeretin induces cell cycle arrest and apoptosis through upregulation of pten expression in glioma cells. Biomed. Pharmacother. 2016, 81, 491-496.
161. Liu, X.; Chen, L.; Liu, Y.; Zhang, T. Tangeretin sensitises human lung cancer cells to trail-induced apoptosis via ros-jnk/erk-chop pathway-mediated up-regulation of death receptor 5. Trop. J. Pharm. Res. 2017, 16, 17-29.
162. Kim, C.D.; Cha, J.D.; Li, S.; Cha, I.H. The mechanism of acacetin-induced apoptosis on oral squamous cell carcinoma. Arch. Oral Biol. 2015, 60, 1283-1298.
163. Kim, H.R.; Park, C.G.; Jung, J.Y. Acacetin (5,7-dihydroxy-40-methoxyflavone) exhibits in vitro and in vivo anticancer activity through the suppression of nf-kb/akt signaling in prostate cancer cells. Int. J. Mol. Med. 2014, 33, 317-324.
164. Yomogida, S. Acacetin induces apoptosis in human t cell leukemia jurkat cells via activation of a caspase cascade. Oncol. Rep. 2011, 204-209.
165. Salimi, A.; Roudkenar, M.H.; Sadeghi, L.; Mohseni, A.; Seydi, E.; Pirahmadi, N.; Pourahmad, J. Selective anticancer activity of acacetin against chronic lymphocytic leukemia using both in vivo and in vitro methods:Key role of oxidative stress and cancerous mitochondria. Nutr. Cancer 2016, 68, 1404-1416.
166. Shen, K.-H.; Hung, S.-H.; Yin, L.-T.; Huang, C.-S.; Chao, C.-H.; Liu, C.-L.; Shih, Y.-W. Acacetin, a flavonoid, inhibits the invasion and migration of human prostate cancer du145 cells via inactivation of the p38 mapk signaling pathway. Mol. Cell. Biochem. 2010, 333, 279-291.
167. Shim, H.-Y.; Park, J.-H.; Paik, H.-D.; Nah, S.-Y.; Kim, D.S.H.L.; Han, Y.S. Molecules and acacetin-induced apoptosis of human breast cancer mcf-7 cells involves caspase cascade, mitochondria-mediated death signaling and sapk/jnk1/2-c-jun activation. Mol. Cells 2007, 24, 95-104.
168. Ni, W.; Ji, J.; Dai, Z.; Papp, A.; Johnson, A.J.; Ahn, S.; Farley, K.L.; Lin, T.S.; Dalton, J.T.; Li, X.; et al. Flavopiridol pharmacogenetics: Clinical and functional evidence for the role of slco1b1/oatp1b1 in flavopiridol disposition. PLoS ONE 2010, 5, e13792.
169. Li, L.; Pongtornpipat, P.; Tiutan, T.; Kendrick, S.L.; Park, S.; Persky, D.O.; Rimsza, L.M.; Puvvada, S.D.; Schatz, J.H. Synergistic induction of apoptosis in high-risk dlbcl by bcl2 inhibition with abt-199 combined with pharmacologic loss of mcl1. Leukemia 2015, 29, 1702-1712.
170. Mahoney, E.; Lucas, D.M.; Gupta, S.V.;Wagner, A.J.; Herman, S.E.M.; Smith, L.L.; Yeh, Y.-Y.; Andritsos, L.; Jones, J.A.; Flynn, J.M.; et al. Er stress and autophagy: New players in the mechanism of action and drug resistance of the cyclin-dependent kinase inhibitor flavopiridol. Blood 2012, 120, 1262-1273.
171. Wiernik, P.H. Alvocidib (flavopiridol) for the treatment of chronic lymphocytic leukemia. Expert Opin. Investig. Drugs 2016, 25, 729-734.
172. Zhang, H.P.; Li, G.Q.; Zhang, Y.; Guo, W.Z.; Zhang, J.K.; Li, J.; Lv, J.F.; Zhang, S.J. Upregulation of mcl-1 inhibits jq1-triggered anticancer activity in hepatocellular carcinoma cells. Biochem. Biophys. Res. Commun. 2018, 495, 2456-2461.
173. Kwak, M.S.; Yu, S.J.; Yoon, J.H.; Lee, S.H.; Lee, S.M.; Lee, J.H.; Kim, Y.J.; Lee, H.S.; Kim, C.Y. Synergistic anti-tumor efficacy of doxorubicin and flavopiridol in an in vivo hepatocellular carcinoma model. J. Cancer Res. Clin. Oncol. 2015, 141, 2037-2045.
174. Gokce, O.; Dogan Turacli, I.; Ilke Onen, H.; Erdem, O.; Erguven Kayaa, E.; Ekmekci, A. Flavopiridol induces apoptosis via mitochondrial pathway in b16f10 murine melanoma cells and a subcutaneous melanoma tumor model. Acta Dermatovenerol. Croat. 2016, 24, 2-12.
175. Zocchi, L.;Wu, S.C.;Wu, J.; Hayama, K.L.; Benavente, C.A. The cyclin-dependent kinase inhibitor flavopiridol (alvocidib) inhibits metastasis of human osteosarcoma cells. Oncotarget 2018, 9, 23505-23518.
176. Huynh, D.L.; Sharma, N.; Kumar Singh, A.; Singh Sodhi, S.; Zhang, J.J.; Mongre, R.K.; Ghosh, M.; Kim, N.; Ho Park, Y.; Kee Jeong, D. Anti-tumor activity of wogonin, an extract from scutellaria baicalensis, through regulating different signaling pathways. Chin. J. Nat. Med. 2017, 15, 15-40.
177. Ge, W.; Yin, Q.; Xian, H. Wogonin induced mitochondrial dysfunction and endoplasmic reticulum stress in human malignant neuroblastoma cells via ire1_-dependent pathway. J. Mol. Neurosci. 2015, 56, 652-662.
178. He, F.;Wang, Q.; Zheng, X.L.; Yan, J.Q.; Yang, L.; Sun, H.; Hu, L.N.; Lin, Y.;Wang, X. Wogonin potentiates cisplatin-induced cancer cell apoptosis through accumulation of intracellular reactive oxygen species. Oncol. Rep. 2012, 28, 601-605.
179. Ruibin, J.; Bo, J.; Danying,W.; Chihong, Z.; Jianguo, F.; Linhui, G. Therapy effects of wogonin on ovarian cancer cells. BioMed Res. Int. 2017, 2017, 9381513.
180. Xu, M.; Lu, N.; Zhang, H.; Dai, Q.; Wei, L.; Li, Z.; You, Q.; Guo, Q. Wogonin induced cytotoxicity in human hepatocellular carcinoma cells by activation of unfolded protein response and inactivation of akt. Hepatol. Res. 2013, 43, 890-905.
181. Li, S.-J.; Sun, S.-J.; Gao, J.; Sun, F.-B. Wogonin induces beclin-1/pi3k and reactive oxygen species-mediated autophagy in human pancreatic cancer cells. Oncol. Lett. 2016, 12, 5059-5067.
182. Androutsopoulos, V.; Arroo, R.R.J.; Hall, J.F.; Surichan, S.; Potter, G.A. Antiproliferative and cytostatic effects of the natural product eupatorin on mda-mb-468 human breast cancer cells due to cyp1-mediated metabolism. Breast Cancer Res. 2008, 10, 1-12.
183. Lee, K.; Hyun Lee, D.; Jung, Y.J.; Shin, S.Y.; Lee, Y.H. The natural flavone eupatorin induces cell cycle arrest at the g2/m phase and apoptosis in hela cells. Appl. Biol. Chem. 2016, 59, 193-199.
184. Sarvestani, N.N.; Sepehri, H.; Farimani, M.M. Anticancer effect of eupatorin via bax/bcl-2 and mitochondrial membrane potential changes through ros mediated pathway in human colon cancer. Int. J. Pharmacogn. Phytochem. Res. 2015, 7, 1039-1046.
185. Sarvestani, N.N.; Sepehri, H.; Delphi, L.; Farimani, M.M. Eupatorin and salvigenin potentiate doxorubicin-induced apoptosis and cell cycle arrest in ht-29 and sw948 human colon cancer cells. Asian Pac. J. Cancer Prev. 2018, 19, 131-139.
186. Estévez, S.; Marrero, M.T.; Quintana, J.; Estévez, F. Eupatorin-induced cell death in human leukemia cells is dependent on caspases and activates the mitogen-activated protein kinase pathway. PLoS ONE 2014, 9, e112536.
187. Fan, Y.; Lu, H.; Ma, H.; Feng, F.; Hu, X.; Zhang, Q.; Wang, J.; Xu, Y.; Zhao, Q. Bioactive compounds of eriocaulon sieboldianum blocking proliferation and inducing apoptosis of hepg2 cells might be involved in aurora kinase inhibition. Food Funct. 2015, 6, 3746-3759.
188. López De Las Hazas, M.C.; Mosele, J.I.; Macià, A.; Ludwig, I.A.; Motilva, M.J. Exploring the colonic metabolism of grape and strawberry anthocyanins and their in vitro apoptotic effects in ht-29 colon cancer cells. J. Agric. Food Chem. 2017, 65, 6477-6487.
189. Wang, L.S.; Stoner, G.D. Anthocyanins and their role in cancer prevention. Cancer Lett. 2008, 269, 281-290.
190. Lin, B.W.; Gong, C.C.; Song, H.F.; Cui, Y.Y. Effects of anthocyanins on the prevention and treatment of cancer. Br. J. Pharmacol. 2017, 174, 1226-1243.
191. Rupasinghe, H.P.V.; Arumuggam, N.; Amararathna, M.; De Silva, A.B.K.H. The potential health benefits of haskap (Lonicera caerulea L.): Role of cyanidin-3-o-glucoside. J. Funct. Foods 2018, 44, 24-39.
192. Sorrenti, V.; Vanella, L.; Acquaviva, R.; Cardile, V.; Giofrè, S.; Di Giacomo, C. Cyanidin induces apoptosis and differentiation in prostate cancer cells. Int. J. Oncol. 2015, 47, 1303-1310.
193. Hosseini, M.M.; Karimi, A.; Behroozaghdam, M.; Javidi, M.A.; Ghiasvand, S.; Bereimipour, A.; Aryan, H.; Nassiri, F.; Jangholi, E. Cytotoxic and apoptogenic effects of cyanidin-3-glucoside on the glioblastoma cell line. World Neurosurg. 2017, 108, 94-100.
194. Tang, J.; Oroudjev, E.; Wilson, L.; Ayoub, G. Delphinidin and cyanidin exhibit antiproliferative and apoptotic effects in mcf7 human breast cancer cells. Integr. Cancer Sci. Ther. 2015, 2, 82-86.
195. Liu, X.; Zhang, D.; Hao, Y.; Liu, Q.; Wu, Y.; Liu, X.; Luo, J.; Zhou, T.; Sun, B.; Luo, X.; et al. Cyanidin curtails renal cell carcinoma tumorigenesis. Cell. Physiol. Biochem. 2018, 46, 2517-2531.
196. Hyun, J.W.; Chung, H.S. Cyanidin and malvidin from oryza sativa cv. Heugjinjubyeo mediate cytotoxicity against human monocytic leukemia cells by arrest of g(2)/m phase and induction of apoptosis. J. Agric. Food Chem. 2004, 52, 2213-2217.
197. Zhou, L.; Wang, H.; Yi, J.; Yang, B.; Li, M.; He, D.; Yang, W.; Zhang, Y.; Ni, H. Anti-tumor properties of anthocyanins from lonicera caerulea ‘beilei’ fruit on human hepatocellular carcinoma: In vitro and in vivo study. Biomed. Pharmacother. 2018, 104, 520-529.
198. Karthi, N.; Kalaiyarasu, T.; Kandakumar, S.; Mariyappan, P.; Manju, V. Pelargonidin induces apoptosis and cell cycle arrest: Via a mitochondria mediated intrinsic apoptotic pathway in ht29 cells. RSC Adv. 2016, 6, 45064-45076.
199. Wang, L.S.; Sun, X.D.; Cao, Y.; Wang, L.; Li, F.J.; Wang, Y.F. Antioxidant and pro-oxidant properties of acylated pelargonidin derivatives extracted from red radish (raphanus sativus var. Niger, brassicaceae). Food Chem. Toxicol. 2010, 48, 2712-2718.
200. Chen, Y.; Wang, S.; Geng, B.; Yi, Z. Pelargonidin induces antitumor effects in human osteosar-Coma cells via autophagy induction, loss of mitochondrial membrane potential, g2/m cell cycle arrest and downregula-tion of pi3k/akt signalling pathway. J. BUON 2018, 23, 735-740.
201. Ko, H.; Jeong, M.-H.; Jeon, H.; Sung, G.-J.; So, Y.; Kim, I.; Son, J.; Lee, S.-W.; Yoon, H.-G.; Choi, K.-C. Delphinidin sensitizes prostate cancer cells to trail-induced apoptosis, by inducing dr5 and causing caspase-mediated hdac3 cleavage. Oncotarget 2015, 6, 9970-9984.
202. Lim,W.; Song, G. Inhibitory effects of delphinidin on the proliferation of ovarian cancer cells via pi3k/akt and erk 1/2 mapk signal transduction. Oncol. Lett. 2017, 14, 810-818.
203. Pal, H.C.; Sharma, S.; Strickland, L.R.; Agarwal, J.; Athar, M.; Elmets, C.A.; Afaq, F. Delphinidin reduces cell proliferation and induces apoptosis of non-small-cell lung cancer cells by targeting egfr/vegfr2 signaling pathways. PLoS ONE 2013, 8, e77270.
204. Alhosin, M.; León-González, A.J.; Dandache, I.; Lelay, A.; Rashid, S.K.; Kevers, C.; Pincemail, J.; Fornecker, L.M.; Mauvieux, L.; Herbrecht, R.; et al. Bilberry extract (antho 50) selectively induces redox-sensitive caspase 3-related apoptosis in chronic lymphocytic leukemia cells by targeting the bcl-2/bad pathway. Sci. Rep. 2015, 5, 1-10.
205. Bin Hafeez, B.; Asim, M.; Siddiqui, I.A.; Adhami, V.M.; Murtaza, I.; Mukhtar, H. Delphinidin, a dietary anthocyanidin in pigmented fruits and vegetables: A new weapon to blunt prostate cancer growth. Cell Cycle 2008, 7, 3320-3326.
206. Hafeez, B.B.; Siddiqui, I.A.; Asim, M.; Malik, A.; Afaq, F.; Adhami, V.M.; Saleem, M.; Din, M.; Mukhtar, H. A dietary anthocyanidin delphinidin induces apoptosis of human prostate cancer pc3 cells in vitro and in vivo: Involvement of nuclear factor-kappab signaling. Cancer Res. 2008, 68, 8564-8572.
207. Li, H.Q.; Luo, Y.; Qiao, C.H. The mechanisms of anticancer agents by genistein and synthetic derivatives of isoflavone. Mini-Rev. Med. Chem. 2012, 12, 350-362.
208. Spagnuolu, C.; Russo, G.L.; Orhan, l.E.; Habtemariam, S.; Daglia, M.; Sureda, A.; Nabavi, S.F.; Devi, K.P.; Loizzo, M.R.; Tundis, R.; et al. Genistein and cancer: Current status, challenges, and future directions. Adv. Nutr. Int. Rev. J. 2015, 6, 408-419.
209. Choi, E.J.; Jung, J.Y.; Kim, G.-H. Genistein inhibits the proliferation and differentiation of mcf-7 and 3t3-l1 cells via the regulation of er_ expression and induction of apoptosis. Exp. Ther. Med. 2014, 8, 454-458.
210. Pan, H.; Zhou, W.; He, W.; Liu, X.; Ding, Q.; Ling, L.; Zha, X.; Wang, S. Genistein inhibits mda-mb-231 triple-negative breast cancer cell growth by inhibiting nf-_b activity via the notch-1 pathway. Int. J. Mol. Med. 2012, 30, 337-343.
211. Ullah, M.F.; Ahmad, A.; Zubair, H.; Khan, H.Y.;Wang, Z.; Sarkar, F.H.; Hadi, S.M. Soy isoflavone genistein induces cell death in breast cancer cells through mobilization of endogenous copper ions and generation of reactive oxygen species. Mol. Nutr. Food Res. 2011, 55, 553-559.
212. Solomon, L.A.; Ali, S.; Banerjee, S.; Munkarah, A.R.; Morris, R.T.; Sarkar, F.H. Sensitization of ovarian cancer cells to cisplatin by genistein: the role of NF-kappaB. J. Ovarian Res. 2008, 1, 9.
213. Szliszka, E.; Krol, W. Soy isoflavones augment the effect of trail-mediated apoptotic death in prostate cancer cells. Oncol. Rep. 2011, 26, 533-541.
214. Dong, X.; Xu, W.; Sikes, R.A.; Wu, C. Combination of low dose of genistein and daidzein has synergistic preventive effects on isogenic human prostate cancer cells when compared with individual soy isoflavone. Food Chem. 2013, 141, 1923-1933.
215. Kumi-Diaka, J.; Merchant, K.; Haces, A.; Hormann, V.; Johnson, M. Genistein-selenium combination induces growth arrest in prostate cancer cells. J. Med. Food 2010, 13, 842-850.
216. Qi, W.; Weber, C.R.; Wasland, K.; Savkovic, S.D. Genistein inhibits proliferation of colon cancer cells by attenuating a negative effect of epidermal growth factor on tumor suppressor foxo3 activity. BMC Cancer 2011, 11, 219.
217. Qin, J.; Teng, J.; Zhu, Z.; Chen, J.; Huang,W.J. Genistein induces activation of the mitochondrial apoptosis pathway by inhibiting phosphorylation of akt in colorectal cancer cells. Pharm. Biol. 2016, 54, 74-79.
218. Shafiee, G.; Saidijam, M.; Tavilani, H.; Ghasemkhani, N.; Khodadadi, I. Genistein induces apoptosis and inhibits proliferation of ht29 colon cancer cells. Int. J. Mol. Cell. Med. 2016, 5, 178-191.
219. Jin, S.; Zhang, Q.Y.; Kang, X.M.; Wang, J.X.; Zhao, W.H. Daidzein induces mcf-7 breast cancer cell apoptosis via the mitochondrial pathway. Ann. Oncol. 2010, 21, 263-268.
220. Liu, X.; Suzuki, N.; Laxmi, Y.R.S.; Okamoto, Y.; Shibutani, S. Anti-breast cancer potential of daidzein in rodents. Life Sci. 2012, 91, 415-419.
221. Park, H.J.; Jeon, Y.K.; You, D.H.; Nam, M.J. Daidzein causes cytochrome c-mediated apoptosis via the bcl-2 family in human hepatic cancer cells. Food Chem. Toxicol. 2013, 60, 542-549.
222. Sak, K. Cytotoxicity of dietary flavonoids on different human cancer types. Pharmacogn. Rev. 2014, 8, 122-146.
223. Siddiqui, I.A.; Asim, M.; Hafeez, B.B.; Adhami, V.M.; Tarapore, R.S.; Mukhtar, H. Green tea polyphenol egcg blunts androgen receptor function in prostate cancer. FASEB J. 2011, 25, 1198-1207.
224. Albrecht, D.S.; Clubbs, E.A.; Ferruzzi, M.; Bomser, J.A. Epigallocatechin-3-gallate (egcg) inhibits pc-3 prostate cancer cell proliferation via mek-independent erk1/2 activation. Chem.-Biol. Interact. 2008, 171, 89-95.
225. Sadava, D.; Whitlock, E.; Kane, S.E. The green tea polyphenol, epigallocatechin-3-gallate inhibits telomerase and induces apoptosis in drug-resistant lung cancer cells. Biochem. Biophys. Res. Commun. 2007, 360, 233-237.
226. Rieger-Christ, K.M.; Hanley, R.; Lodowsky, C.; Bernier, T.; Vemulapalli, P.; Roth, M.; Kim, J.; Yee, A.S.; Le, S.M.; Marie, P.J.; et al. The green tea compound, (-)-epigallocatechin-3-gallate downregulates n-cadherin and suppresses migration of bladder carcinoma cells. J. Cell. Biochem. 2007, 102, 377-388.
227. Righeschi, C.; Eichhorn, T.; Karioti, A.; Bilia, A.R.; Efferth, T. Microarray-based mrna expression profiling of leukemia cells treated with the flavonoid, casticin. Cancer Genom. Proteomics 2012, 9, 143-151.
228. Liu, F.; Cao, X.; Liu, Z.; Guo, H.; Ren, K.; Quan, M.; Zhou, Y.; Xiang, H.; Cao, J. Casticin suppresses self-renewal and invasion of lung cancer stem-like cells from a549 cells through down-regulation of pakt. Acta Biochim. Biophys. Sin. 2014, 46, 15-21.
229. Shen, J.-K.; Du, H.-P.; Yang, M.;Wang, Y.-G.; Jin, J. Casticin induces leukemic cell death through apoptosis and mitotic catastrophe. Ann.Hematol. 2009, 88, 743-752.
230. Roh, J.S.; Han, J.Y.; Kim, J.H.; Hwang, J.K. Inhibitory effects of active compounds isolated from safflower (Carthamus tinctorius L.) seeds for melanogenesis. Biol. Pharm. Bull. 2004, 27, 1976-1978.
231. Wirger, A.; Perabo, F.G.E.; Burgemeister, S.; Haase, L.; Schmidt, D.H.; Doehn, C.; Mueller, S.C.; Jocham, D. Flavopiridol, an inhibitor of cyclin-dependent kinases, induces growth inhibition and apoptosis in bladder cancer cells in vitro and in vivo. Anticancer Res. 2005, 25, 4341-4347.
232. Mayer, F.; Mueller, S.; Malenke, E.; Kuczyk, M.; Hartmann, J.T.; Bokemeyer, C. Induction of apoptosis by flavopiridol unrelated to cell cycle arrest in germ cell tumour derived cell lines. Investig. New Drugs 2005, 23, 205-211.
233. Schrump, D.S.; Matthews,W.; Chen, G.A.; Mixon, A.; Altorki, N.K. Flavopiridol mediates cell cycle arrest and apoptosis in esophageal cancer cells. Clin Cancer Res. 1998, 4, 2885-2890.
234. Patel, V.; Senderowicz, A.M.; Pinto, D., Jr.; Igishi, T.; Raffeld, M.; Quintanilla-Martinez, L.; Ensley, J.F.; Sausville, E.A.; Gutkind, J.S. Flavopiridol, a novel cyclin-dependent kinase inhibitor, suppresses the growth of head and neck squamous cell carcinomas by inducing apoptosis. J. Clin. Investig. 1998, 102, 1674-1681.
235. Parker, B.W.; Kaur, G.; Nieves-Neira,W.; Taimi, M.; Kohlhagen, G.; Shimizu, T.; Losiewicz, M.D.; Pommier, Y.; Sausville, E.A.; Senderowicz, A.M. Early induction of apoptosis in hematopoietic cell lines after exposure to flavopiridol. Blood 1998, 91, 458-465.
236. Dolečková, I.; Rárová, L.; Grúz, J.; Vondrusová, M.; Strnad, M.; Kryštof, V. Antiproliferative and antiangiogenic effects of flavone eupatorin, an active constituent of chloroform extract of orthosiphon stamineus leaves. Fitoterapia 2012, 83, 1000-1007.
237. Yoshino, Y.; Yuan, B.; Okusumi, S.; Aoyama, R.; Murota, R.; Kikuchi, H.; Takagi, N.; Toyoda, H. Enhanced cytotoxic effects of arsenite in combination with anthocyanidin compound, delphinidin, against a human leukemia cell line, hl-60. Chem.-Biol. Interact. 2018, 294, 9-17.
238. Kamenickova, A.; Anzenbacherova, E.; Pavek, P.; Soshilov, A.A.; Denison, M.S.; Anzenbacher, P.; Dvorak, Z. Pelargonidin activates the ahr and induces cyp1a1 in primary human hepatocytes and human cancer cell lines hepg2 and ls174t. Toxico. Lett. 2013, 218, 253-259.
239. Sanaei, M.; Kavoosi, F.; Valiani, A.; Ghobadifar, M.A. Effect of genistein on apoptosis and proliferation of hepatocellular carcinoma hepa1-6 cell line. Int. J. Prev. Med. 2018, 9, 12.
240. Bi, Y.L.; Min, M.; Shen,W.; Liu, Y. Genistein induced anticancer effects on pancreatic cancer cell lines involves mitochondrial apoptosis, g0/g1cell cycle arrest and regulation of stat3 signalling pathway. Phytomed. Int. J. Phytother. Phytopharmacol. 2018, 39, 10-16.
241. Gundogdu, G.; Dodurga, Y.; Cetin, M.; Secme, M.; Cicek, B. The cytotoxic and genotoxic effects of daidzein on mia paca-2 human pancreatic carcinoma cells and ht-29 human colon cancer cells. Drug chem. Toxicol. 2018.
242. Hua, F.; Li, C.H.; Chen, X.G.; Liu, X.P. Daidzein exerts anticancer activity towards skov3 human ovarian cancer cells by inducing apoptosis and cell cycle arrest, and inhibiting the raf/mek/erk cascade. Int. J. Mol. Med. 2018, 41, 3485-3492.
243. Han, B.-J.; Li,W.; Jiang, G.-B.; Lai, S.-H.; Zhang, C.; Zeng, C.-C.; Liu, Y.-J. Effects of daidzein in regards to cytotoxicity in vitro, apoptosis, reactive oxygen species level, cell cycle arrest and the expression of caspase and bcl-2 family proteins. Oncol. Rep. 2015, 34, 1115-1120.
244. Hollman, P.C.H. Absorption, bioavailability, and metabolism of flavonoids. Pharm. Biol. 2004, 42, 74-83.
245. Manach, C.; Scalbert, A.; Morand, C.; Remesy, C.; Jimenez, L. Polyphenols: Food sources and bioavailability. Am. J. Clin. Nutr. 2004, 79, 727-747.
246. Viskupičová, J.; Ondrejovič, M.; Šturdík, E. Bioavailability and metabolism of flavonoids. J. Food Nutr. Res. 2008, 47, 151-162.
247. Cassidy, A.; Minihane, A.M. The role of metabolism (and the microbiome) in defining the clinical efficacy of dietary flavonoids. Am. J. Clin. Nutr. 2017, 105, 10-22.
248. Scalbert, A.;Williamson, G. Dietary intake and bioavailability of polyphenols. J. Nutr. 2000, 130, 2073S-2085S.
249. Hu, M.; Wu, B.; Liu, Z. Bioavailability of polyphenols and flavonoids in the era of precision medicine. Mol. Pharm. 2017, 14, 2861-2863.
250. Thilakarathna, S.H.; Rupasinghe, H.P. Flavonoid bioavailability and attempts for bioavailability enhancement. Nutrients 2013, 5, 3367-3387.
251. Barnes, S. Soy isoflavones-phytoestrogens and what else? J. Nutr. 2004, 134, 1225S-1228S.
252. Messina, M.J.; Loprinzi, C.L. Soy for breast cancer survivors: A critical review of the literature. J. Nutr. 2001, 131, 3095S-3108S.
253. Wang, S.; Zhang, J.; Chen, M.; Wang, Y. Delivering flavonoids into solid tumors using nanotechnologies. Expert Opin. Drug Deliv. 2013, 10, 1411-1428.
254. Goniotaki, M.; Hatziantoniou, S.; Dimas, K.; Wagner, M.; Demetzos, C. Encapsulation of naturally occurring flavonoids into liposomes: Physicochemical properties and biological activity against human cancer cell lines. J. Pharm. Pharmacol. 2004, 56, 1217-1224.
255. Guo, D.; Wu, C.; Li, J.; Guo, A.; Li, Q.; Jiang, H.; Chen, B.; Wang, X. Synergistic effect of functionalized nickel nanoparticles and quercetin on inhibition of the smmc-7721 cells proliferation. Nanoscale Res. Lett. 2009, 4, 1395-1402.
256. Wong, M.Y.; Chiu, G.N. Liposome formulation of co-encapsulated vincristine and quercetin enhanced antitumor activity in a trastuzumab-insensitive breast tumor xenograft model. Nanomedicine 2011, 7, 834-840.
257. Han, Q.; Yang, R.; Li, J.; Liang, W.; Zhang, Y.; Dong, M.; Besenbacher, F.; Wang, C. Enhancement of biological activities of nanostructured hydrophobic drug species. Nanoscale 2012, 4, 2078-2082.
258. Yuan, Z.P.; Chen, L.J.;Wei, Y.Q.; Fan, L.Y.; Tang, M.H.; Yang, G.L. Nanoliposomal quercetin inhibits formation of malignant ascites of hepatocellular carcinoma. Ai Zheng 2006, 25, 941-945.
259. Yuan, Z.P.; Chen, L.J.; Fan, L.Y.; Tang, M.H.; Yang, G.L.; Yang, H.S.; Du, X.B.; Wang, G.Q.; Yao, W.X.; Zhao, Q.M.; et al. Liposomal quercetin efficiently suppresses growth of solid tumors in murine models. Clin. Cancer Res. 2006, 12, 3193-3199.
260. Ferrer, P.; Asensi, M.; Segarra, R.; Ortega, A.; Benlloch, M.; Obrador, E.; Varea, M.T.; Asensio, G.; Jorda, L.; Estrela, J.M. Association between pterostilbene and quercetin inhibits metastatic activity of b16 melanoma. Neoplasia 2005, 7, 37-47.
261. Harper, C.E.; Cook, L.M.; Patel, B.B.; Wang, J.; Eltoum, I.A.; Arabshahi, A.; Shirai, T.; Lamartiniere, C.A. Genistein and resveratrol, alone and in combination, suppress prostate cancer in sv-40 tag rats. Prostate 2009, 69, 1668-1682.
262. Sakamoto, K. Synergistic effects of thearubigin and genistein on human prostate tumor cell (pc-3) growth via cell cycle arrest. Cancer Lett. 2000, 151, 103-109.
263. Wang, P.; Heber, D.; Henning, S.M. Quercetin increased bioavailability and decreased methylation of green tea polyphenols in vitro and in vivo. Food Funct. 2012, 3, 635-642.
264. Wang, P.; Vadgama, J.V.; Said, J.W.; Magyar, C.E.; Doan, N.; Heber, D.; Henning, S.M. Enhanced inhibition of prostate cancer xenograft tumor growth by combining quercetin and green tea. J. Nutr. Biochem. 2014, 25, 73-80.
265. Amin, A.R.; Wang, D.; Zhang, H.; Peng, S.; Shin, H.J.; Brandes, J.C.; Tighiouart, M.; Khuri, F.R.; Chen, Z.G.; Shin, D.M. Enhanced anti-tumor activity by the combination of the natural compounds (-)-epigallocatechin-3-gallate and luteolin: Potential role of p53. J. Biol. Chem. 2010, 285, 34557-34565.
266. Somers-Edgar, T.J.; Scandlyn, M.J.; Stuart, E.C.; Le Nedelec, M.J.; Valentine, S.P.; Rosengren, R.J. The combination of epigallocatechin gallate and curcumin suppresses er alpha-breast cancer cell growth in vitro and in vivo. Int. J. Cancer 2008, 122, 1966-1971.
267. Mertens-Talcott, S.U.; Bomser, J.A.; Romero, C.; Talcott, S.T.; Percival, S.S. Ellagic acid potentiates the effect of quercetin on p21waf1/cip1, p53, and map-kinases without affecting intracellular generation of reactive oxygen species in vitro. J. Nutr. 2005, 135, 609-614.
268. Mertens-Talcott, S.U.; Percival, S.S. Ellagic acid and quercetin interact synergistically with resveratrol in the induction of apoptosis and cause transient cell cycle arrest in human leukemia cells. Cancer Lett. 2005, 218, 141-151.
269. Mertens-Talcott, S.U.; Talcott, S.T.; Percival, S.S. Low concentrations of quercetin and ellagic acid synergistically influence proliferation, cytotoxicity and apoptosis in molt-4 human leukemia cells. J. Nutr. 2003, 133, 2669-2674.
270. Suganuma, M.; Okabe, S.; Kai, Y.; Sueoka, N.; Sueoka, E.; Fujiki, H. Synergistic effects of (-)-epigallocatechin gallate with (-)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line pc-9. Cancer Res. 1999, 59, 44-47.
271. Suganuma, M.; Kurusu, M.; Suzuki, K.; Tasaki, E.; Fujiki, H. Green tea polyphenol stimulates cancer preventive effects of celecoxib in human lung cancer cells by upregulation of gadd153 gene. Int. J. Cancer 2006, 119, 33-40.
272. Adhami, V.M.; Malik, A.; Zaman, N.; Sarfaraz, S.; Siddiqui, I.A.; Syed, D.N.; Afaq, F.; Pasha, F.S.; Saleem, M.; Mukhtar, H. Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo. Clin. Cancer Res. 2007, 13, 1611-1619.
273. Stearns, M.E.; Wang, M. Synergistic effects of the green tea extract epigallocatechin-3-gallate and taxane in eradication of malignant human prostate tumors. Transl. Oncol. 2011, 4, 147-156.
274. Stearns, M.E.; Amatangelo, M.D.; Varma, D.; Sell, C.; Goodyear, S.M. Combination therapy with epigallocatechin-3-gallate and doxorubicin in human prostate tumor modeling studies: Inhibition of metastatic tumor growth in severe combined immunodeficiency mice. Am. J. Pathol. 2010, 177, 3169-3179.
275. Liang, G.; Tang, A.; Lin, X.; Li, L.; Zhang, S.; Huang, Z.; Tang, H.; Li, Q.Q. Green tea catechins augment the antitumor activity of doxorubicin in an in vivo mouse model for chemoresistant liver cancer. Int. J. Oncol. 2010, 37, 111-123.
276. Luo, T.; Wang, J.; Yin, Y.; Hua, H.; Jing, J.; Sun, X.; Li, M.; Zhang, Y.; Jiang, Y. (-)-epigallocatechin gallate sensitizes breast cancer cells to paclitaxel in a murine model of breast carcinoma. Breast Cancer Res. 2010, 12, R8.
277. Chan, M.M.; Soprano, K.J.;Weinstein, K.; Fong, D. Epigallocatechin-3-gallate delivers hydrogen peroxide to induce death of ovarian cancer cells and enhances their cisplatin susceptibility. J. Cell Physiol. 2006, 207, 389-396.
278. Tang, S.N.; Fu, J.; Shankar, S.; Srivastava, R.K. Egcg enhances the therapeutic potential of gemcitabine and cp690550 by inhibiting stat3 signaling pathway in human pancreatic cancer. PLoS ONE 2012, 7, e31067.
279. Staedler, D.; Idrizi, E.; Kenzaoui, B.H.; Juillerat-Jeanneret, L. Drug combinations with quercetin: Doxorubicin plus quercetin in human breast cancer cells. Cancer Chemother. Pharmacol. 2011, 68, 1161-1172.
280. Sharma, H.; Sen, S.; Singh, N. Molecular pathways in the chemosensitization of cisplatin by quercetin in human head and neck cancer. Cancer Biol. Ther. 2005, 4, 949-955.
281. Banerjee, S.; Zhang, Y.; Ali, S.; Bhuiyan, M.; Wang, Z.; Chiao, P.J.; Philip, P.A.; Abbruzzese, J.; Sarkar, F.H. Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer. Cancer Res. 2005, 65, 9064-9072.
282. Mohammad, R.M.; Banerjee, S.; Li, Y.; Aboukameel, A.; Kucuk, O.; Sarkar, F.H. Cisplatin-induced antitumor activity is potentiated by the soy isoflavone genistein in bxpc-3 pancreatic tumor xenografts. Cancer 2006, 106, 1260-1268.
283. Banerjee, S.; Zhang, Y.; Wang, Z.; Che, M.; Chiao, P.J.; Abbruzzese, J.L.; Sarkar, F.H. In vitro and in vivo molecular evidence of genistein action in augmenting the efficacy of cisplatin in pancreatic cancer. Int. J. Cancer 2007, 120, 906-917.
284. Raffoul, J.J.; Sarkar, F.H.; Hillman, G.G. Radiosensitization of prostate cancer by soy isoflavones. Curr. Cancer Drug Targets 2007, 7, 759-765.
285. Raffoul, J.J.; Banerjee, S.; Singh-Gupta, V.; Knoll, Z.E.; Fite, A.; Zhang, H.; Abrams, J.; Sarkar, F.H.; Hillman, G.G. Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo. Cancer Res. 2007, 67, 2141-2149.
286. Raffoul, J.J.; Banerjee, S.; Che, M.; Knoll, Z.E.; Doerge, D.R.; Abrams, J.; Kucuk, O.; Sarkar, F.H.; Hillman, G.G. Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model. Int. J. Cancer 2007, 120, 2491-2498.
287. Gupta, S.C.; Patchva, S.; Aggarwal, B.B. Therapeutic roles of curcumin: Lessons learned from clinical trials. AAPS J. 2013, 15, 195-218.
288. Kanwar, J.; Taskeen, M.; Mohammad, I.; Huo, C.; Chan, T.H.; Dou, Q.P. Recent advances on tea polyphenols. Front. Biosci. 2012, 4, 111-131.
289. Saldanha, S.N.; Tollefsbol, T.O. The role of nutraceuticals in chemoprevention and chemotherapy and their clinical outcomes. J. Oncol. 2012, 2012, 192464.
290. Paller, C.J.; Rudek, M.A.; Zhou, X.C.; Wagner,W.D.; Hudson, T.S.; Anders, N.; Hammers, H.J.; Dowling, D.; King, S.; Antonarakis, E.S.; et al. A phase i study of muscadine grape skin extract in men with biochemically recurrent prostate cancer: Safety, tolerability, and dose determination. Prostate 2015, 75, 1518-1525.
291. Zhang, G.;Wang, Y.; Zhang, Y.;Wan, X.; Li, J.; Liu, K.;Wang, F.; Liu, K.; Liu, Q.; Yang, C.; et al. Anti-cancer activities of tea epigallocatechin-3-gallate in breast cancer patients under radiotherapy. Curr. Mol. Med. 2012, 12, 163-176.